Arcturus Therapeutics Holdings, Inc. (ARCT)
15.19
-0.98
(-6.06%)
USD |
NASDAQ |
Aug 28, 16:00
15.18
-0.01
(-0.07%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Market Cap : 431.75M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 431.75M |
| August 27, 2026 | 459.60M |
| August 26, 2026 | 449.94M |
| August 25, 2026 | 438.85M |
| August 24, 2026 | 407.59M |
| August 21, 2026 | 382.29M |
| August 20, 2026 | 312.37M |
| August 19, 2026 | 292.19M |
| August 18, 2026 | 233.35M |
| August 17, 2026 | 231.36M |
| August 14, 2026 | 233.92M |
| August 13, 2026 | 223.40M |
| August 12, 2026 | 216.01M |
| August 11, 2026 | 213.74M |
| August 10, 2026 | 200.38M |
| August 07, 2026 | 210.61M |
| August 06, 2026 | 172.81M |
| August 05, 2026 | 177.93M |
| August 04, 2026 | 176.79M |
| August 03, 2026 | 170.54M |
| July 31, 2026 | 163.72M |
| July 30, 2026 | 168.26M |
| July 29, 2026 | 164.57M |
| July 28, 2026 | 163.43M |
| July 27, 2026 | 163.72M |
| Date | Value |
|---|---|
| July 24, 2026 | 157.18M |
| July 23, 2026 | 164.57M |
| July 22, 2026 | 168.55M |
| July 21, 2026 | 170.25M |
| July 20, 2026 | 169.69M |
| July 17, 2026 | 171.96M |
| July 16, 2026 | 175.65M |
| July 15, 2026 | 181.62M |
| July 14, 2026 | 181.05M |
| July 13, 2026 | 190.72M |
| July 10, 2026 | 198.11M |
| July 09, 2026 | 203.51M |
| July 08, 2026 | 207.49M |
| July 07, 2026 | 216.01M |
| July 06, 2026 | 208.91M |
| July 02, 2026 | 206.92M |
| July 01, 2026 | 195.83M |
| June 30, 2026 | 191.00M |
| June 29, 2026 | 193.84M |
| June 26, 2026 | 195.55M |
| June 25, 2026 | 193.84M |
| June 24, 2026 | 199.25M |
| June 23, 2026 | 201.23M |
| June 22, 2026 | 205.50M |
| June 18, 2026 | 214.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Exelixis, Inc. | 13.55B |
| PTC Therapeutics, Inc. | 5.840B |
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
| Anika Therapeutics, Inc. | 282.38M |
Market Cap Related Metrics
| PS Ratio | 22.74 |
| PEG Ratio | -0.0935 |
| Price to Book Value | 2.513 |
| Price | 15.19 |
| Earnings Yield | -21.82% |
| PEGY Ratio | -0.0935 |